2BB score and signals
Boundless Bio, Inc.’s current 2BB score is 14 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 24 | Weak |
| Quality | 60 | Strong |
| Risk | 46 | Moderate |
2BBBullish & Bearish
Boundless Bio, Inc. (BOLD) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 14 out of 100.
Boundless Bio, Inc.’s current 2BB score is 14 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 24 | Weak |
| Quality | 60 | Strong |
| Risk | 46 | Moderate |
| Founded | 2018 |
| Employees | 28 |
| 52-week range | $0.96 – $2.97 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-03 | — | -0.5712 | — | $0.00 |
| 2026-08-17 | — | -0.5916 | — | $0.00 |
| 2026-05-08 | -0.6 | -0.5882 | $0.00 | $0.00 |
| 2026-03-09 | -0.58 | -0.5304 | $0.00 | $0.00 |